BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan X, Wu HH, Chen Z, Du GW, Bai XJ, Tuoheti K, Liu TZ. Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer. Front Oncol 2021;11:632387. [PMID: 34221960 DOI: 10.3389/fonc.2021.632387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lyu X, Qiang Y, Zhang B, Xu W, Cui Y, Ma L. Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction. Front Oncol 2022;12:1016542. [PMID: 36408130 DOI: 10.3389/fonc.2022.1016542] [Reference Citation Analysis]
2 Chen H, Zhou T, Wang Y, Wen S, Dao P, Chen M. Key molecules in bladder cancer affect patient prognosis and immunotherapy efficacy: further exploration for CNTN1 and EMP1.. [DOI: 10.21203/rs.3.rs-2142421/v1] [Reference Citation Analysis]
3 Wang J, Zhu J, Tang Y, Zhang A, Zhou T, Zhou Y, Shi J, Liu X. Characteristic of Molecular Subtypes in Lung Squamous Cell Carcinoma Based on Autophagy-Related Genes and Tumor Microenvironment Infiltration. Journal of Oncology 2022;2022:1-18. [DOI: 10.1155/2022/3528142] [Reference Citation Analysis]
4 Yu J, Mao W, Sun S, Hu Q, Wang C, Xu Z, Liu R, Chen S, Xu B, Chen M. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer. Cancer Manag Res 2022;14:67-88. [PMID: 35023971 DOI: 10.2147/CMAR.S346240] [Reference Citation Analysis]